Explore All Access
Check if your research matches the topics covered in Anti-Cancer Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Anti-Cancer Drugs : Impact Factor & More
eISSN: 1473-5741pISSN: 0959-4973
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope of Anti-Cancer Drugs
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. Less
Anti-Cancer Drugs Key Metrics
CiteScore 
5.2
H-Index
98
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.52
Topics Covered on Anti-Cancer Drugs
Anti-Cancer Drugs Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Anti-Cancer Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Anti-Cancer Drugs
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
- 1 Apr 2025
- Anti-cancer drugs
Correlative analysis of immune-related thyroid dysfunction and prognosis in patients with advanced esophageal squamous cell carcinoma.
- 21 Mar 2025
- Anti-cancer drugs
Treatment of RET/ALK comutated advanced lung large cell neuroendocrine carcinoma: a case report and literature review.
- 21 Mar 2025
- Anti-cancer drugs
Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation.
- 18 Mar 2025
- Anti-cancer drugs
GZ17-6.02 interacts with carboplatin and etoposide to kill neuroblastoma cells.
- 12 Mar 2025
- Anti-cancer drugs
FV-429 suppresses cancer cell migration and invasion by EMT via the Hippo/YAP1 pathway in pancreatic cancer cells.
- 12 Mar 2025
- Anti-cancer drugs
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
- 1 Apr 2025
- Anti-cancer drugs
Correlative analysis of immune-related thyroid dysfunction and prognosis in patients with advanced esophageal squamous cell carcinoma.
- 21 Mar 2025
- Anti-cancer drugs
Treatment of RET/ALK comutated advanced lung large cell neuroendocrine carcinoma: a case report and literature review.
- 21 Mar 2025
- Anti-cancer drugs
Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation.
- 18 Mar 2025
- Anti-cancer drugs
GZ17-6.02 interacts with carboplatin and etoposide to kill neuroblastoma cells.
- 12 Mar 2025
- Anti-cancer drugs
FV-429 suppresses cancer cell migration and invasion by EMT via the Hippo/YAP1 pathway in pancreatic cancer cells.
- 12 Mar 2025
- Anti-cancer drugs
Compare Similar Journals with Anti-Cancer Drugs
Select Journals to Compare with Anti-Cancer Drugs
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Cancers
Publisher: MDPI
Oncotarget
Publisher: Impact Journals
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Oncology Reports
Publisher: SPANDIDOS PUBL LTD
Annals of Oncology
Publisher: ELSEVIER
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
0 Journals Selected to compare with
Anti-Cancer Drugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
